Aspergillus fumigatus empyema, arthritis, in a lung transplant patient successfully and calcaneal osteomyelitis treated with posaconazole

被引：46

作者：

Lodge, BA

Ashley, ED

Steele, MP

Perfect, JR

机构：

[1] Duke Univ, Med Ctr, Clin Mycol Lab, Transplant Infect Dis Serv, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27710 USA

[3] Duke Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Durham, NC 27710 USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2004年 / 42卷 / 03期

关键词：

D O I：

10.1128/JCM.42.3.1376-1378.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A 64-year-old male with Aspergillus fumigatus infection that had disseminated from the lung to the ankle and adjacent bone was treated successfully with posaconazole after therapy with itraconazole and amphotericin B lipid complex failed. Marked clinical improvement occurred within 6 weeks of initiation of posaconazole therapy; after 6 months, infection had resolved at all sites. The patient has had no recurrence of infection.

引用

页码：1376 / 1378

页数：3

共 9 条

[1]

CORTET B, 1994, J RHEUMATOL, V21, P1287

[2]

Faure B T, 1990, Orthop Rev, V19, P58

[3]

HUMMEL M, 1993, J HEART LUNG TRANSPL, V12, P599

[4] A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592) [J].